healthcare News
Apogee Therapeutics surges 19% on positive eczema drug trial data
Phase 2 APEX trial shows durable response with less frequent dosing, positioning drug for Phase 3 in second half of 2026
Insmed ARIKAYCE study meets all endpoints despite 5.6% stock decline
Phase 3b ENCORE trial shows statistically significant improvements in MAC lung disease patients, supporting label expansion to broader patient population
Talphera beats EPS expectations on 50% enrollment milestone
Biotech raises 2026 guidance to fund NEPHRO CRRT trial completion as PMA filing looms
Avalo Therapeutics plunges 29% as 2025 loss widens to $78.3M
Biotech's $50.1M R&D spend for Phase 2 LOTUS trial drives earnings miss ahead of Q2 2026 data catalyst
Bristol Myers Opdivo approval spurs trading volume despite share decline
FDA expands flagship cancer drug to untreated Hodgkin lymphoma, potentially adding billions in revenue as institutional investors take positions
Milestone Pharmaceuticals' CARDAMYST launch tests investor patience
Commercial execution underway but mounting losses weigh on pre-commercial company as $200M cash runway provides buffer into 2027
Novartis to acquire breast cancer drug SNV4818 for up to $3B
Pan-mutant selective PI3Kα inhibitor targets 40% of HR+/HER2- breast cancer patients with worse prognosis
Alumis shares jump 82% on Phase 3 success for psoriasis drug
Biotech plans FDA submission for ESK-001 in second half of 2026, marking first potential commercial product